<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">58699</article-id><article-id pub-id-type="doi">10.7554/eLife.58699</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>The contribution of asymptomatic SARS-CoV-2 infections to transmission on the Diamond Princess cruise ship</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-187387"><name><surname>Emery</surname><given-names>Jon C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187389"><name><surname>Russell</surname><given-names>Timothy W</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187385"><name><surname>Liu</surname><given-names>Yang</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-8"/><xref ref-type="other" rid="par-10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187386"><name><surname>Hellewell</surname><given-names>Joel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187388"><name><surname>Pearson</surname><given-names>Carl AB</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><collab>CMMID COVID-19 Working Group</collab></contrib><contrib contrib-type="author" id="author-21266"><name><surname>Knight</surname><given-names>Gwenan M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7263-9896</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-52045"><name><surname>Eggo</surname><given-names>Rosalind M</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-9"/><xref ref-type="other" rid="par-11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21671"><name><surname>Kucharski</surname><given-names>Adam J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8814-9421</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18737"><name><surname>Funk</surname><given-names>Sebastian</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2842-3406</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-35621"><name><surname>Flasche</surname><given-names>Stefan</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-20270"><name><surname>Houben</surname><given-names>Rein M G J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4132-7467</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Faculty of Epidemiology and Population Health</institution>, <institution>London School of Hygiene and Tropical Medicine</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">IDE</institution>, <institution>London School of Hygiene and Tropical Medicine</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">Centre for the Mathematical Modelling of Infectious Diseases</institution>, <institution>London School of Hygiene and Tropical Medicine</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff4"><institution content-type="dept">Infectious Disease Epidemiology</institution>, <institution>London School of Hygiene and Tropical Medicine</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-16032"><name><surname>Lipsitch</surname><given-names>Marc</given-names></name><role>Reviewing editor</role><aff><institution>Harvard TH Chan School of Public Health</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>rein.houben@lshtm.ac.uk</email> (RH);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>24</day><month>08</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e58699</elocation-id><history><date date-type="received"><day>08</day><month>05</month><year>2020</year></date><date date-type="accepted"><day>23</day><month>08</month><year>2020</year></date></history><permissions><copyright-statement>Â© 2020, Emery et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Emery et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-58699-v1.pdf"/><abstract><p>A key unknown for SARS-CoV-2 is how asymptomatic infections contribute to transmission. We used a transmission model with asymptomatic and presymptomatic states, calibrated to data on disease onset and test frequency from the Diamond Princess cruise ship outbreak, to quantify the contribution of asymptomatic infections to transmission. The model estimated that 74% (70-78%, 95% posterior interval) of infections proceeded asymptomatically. Despite intense testing, 53% (51-56%) of infections remained undetected, most of them asymptomatic. Asymptomatic individuals were the source for 69% (20-85%) of all infections. The data did not allow identification of the infectiousness of asymptomatic infections, however low ranges (0-25%) required a net reproduction number for individuals progressing through presymptomatic and symptomatic stages of at least 15. Asymptomatic SARS-CoV-2 infections may contribute substantially to transmission. Control measures, and models projecting their potential impact, need to look beyond the symptomatic cases if they are to understand and address ongoing transmission.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>European Research Council Starting Grant</institution></institution-wrap></funding-source><award-id>Action Number 757699</award-id><principal-award-recipient><name><surname>Emery</surname><given-names>Jon C</given-names></name><name><surname>Houben</surname><given-names>Rein M G J</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>206250/Z/17/Z</award-id><principal-award-recipient><name><surname>Russell</surname><given-names>Timothy W</given-names></name><name><surname>Kucharski</surname><given-names>Adam J</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>208812/Z/17/Z</award-id><principal-award-recipient><name><surname>Flasche</surname><given-names>Stefan</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>210758/Z/18/Z</award-id><principal-award-recipient><name><surname>Hellewell</surname><given-names>Joel</given-names></name><name><surname>Funk</surname><given-names>Sebastian</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000865</institution-id><institution>Bill and Melinda Gates Foundation</institution></institution-wrap></funding-source><award-id>INV-003174</award-id><principal-award-recipient><name><surname>Liu</surname><given-names>Yang</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000865</institution-id><institution>Bill and Melinda Gates Foundation</institution></institution-wrap></funding-source><award-id>NTD Modelling Consortium OPP1184344</award-id><principal-award-recipient><name><surname>Pearson</surname><given-names>Carl AB</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution>DFID/Wellcome Trust</institution></institution-wrap></funding-source><award-id>Epidemic Preparedness Coronavirus research programme 221303/Z/20/Z</award-id><principal-award-recipient><name><surname>Pearson</surname><given-names>Carl AB</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution>European Union Horizon 2020</institution></institution-wrap></funding-source><award-id>project EpiPose (101003688)</award-id><principal-award-recipient><name><surname>Liu</surname><given-names>Yang</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution>HDR UK</institution></institution-wrap></funding-source><award-id>MR/S003975/1</award-id><principal-award-recipient><name><surname>Eggo</surname><given-names>Rosalind M</given-names></name></principal-award-recipient></award-group><award-group id="par-10"><funding-source><institution-wrap><institution>National Institute for Health Research</institution></institution-wrap></funding-source><award-id>16/137/109</award-id><principal-award-recipient><name><surname>Liu</surname><given-names>Yang</given-names></name></principal-award-recipient></award-group><award-group id="par-11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MC_PC 19065</award-id><principal-award-recipient><name><surname>Eggo</surname><given-names>Rosalind M</given-names></name></principal-award-recipient></award-group><award-group id="par-12"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MR/P014658/1</award-id><principal-award-recipient><name><surname>Knight</surname><given-names>Gwenan M</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data analysed during this study are included in the manuscript and supporting files. Model code is available through github.</p></sec><supplementary-material><ext-link xlink:href="elife-58699-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>